Alliancebernstein L.P. Purchases 174,290 Shares of UnitedHealth Group Incorporated (UNH)

Alliancebernstein L.P. lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,906,936 shares of the healthcare conglomerate’s stock after acquiring an additional 174,290 shares during the quarter. UnitedHealth Group accounts for approximately 1.1% of Alliancebernstein L.P.’s portfolio, making the stock its 8th largest holding. Alliancebernstein L.P. owned about 0.80% of UnitedHealth Group worth $1,466,104,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Patriot Financial Group Insurance Agency LLC grew its position in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the period. Blue Chip Partners Inc. acquired a new position in UnitedHealth Group during the second quarter worth about $110,000. Kings Point Capital Management grew its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the period. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after buying an additional 520 shares during the period. Finally, BDO Wealth Advisors LLC acquired a new position in UnitedHealth Group during the second quarter worth about $121,000. Institutional investors and hedge funds own 86.00% of the company’s stock.

UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.71 on Wednesday. UnitedHealth Group Incorporated has a one year low of $148.56 and a one year high of $213.93. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The company has a market cap of $204,541.08, a price-to-earnings ratio of 21.99, a PEG ratio of 1.57 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The business had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter last year, the firm posted $2.17 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. sell-side analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 33.26%.

WARNING: “Alliancebernstein L.P. Purchases 174,290 Shares of UnitedHealth Group Incorporated (UNH)” was first posted by Markets Daily and is owned by of Markets Daily. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.themarketsdaily.com/2017/11/15/alliancebernstein-l-p-purchases-174290-shares-of-unitedhealth-group-incorporated-unh.html.

Several brokerages have weighed in on UNH. Royal Bank Of Canada restated a “buy” rating and set a $212.00 target price on shares of UnitedHealth Group in a research report on Thursday, July 20th. Citigroup Inc. increased their price target on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $210.00 price target (up from $190.00) on shares of UnitedHealth Group in a research report on Saturday, July 22nd. Cowen and Company reiterated an “outperform” rating and issued a $220.00 price target (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price target on the stock in a research report on Tuesday, August 1st. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $216.65.

In other news, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the transaction, the insider now owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. In the last three months, insiders sold 72,149 shares of company stock worth $14,212,342. Insiders own 0.89% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply